Navigating Innovation, Evidence-based Practice and Patient Choice in ART: Concluding Comments on Adjuvant Therapies

Thomas Tang; Nikoletta Panagiotopoulou; Ephia Yasmin

doi:10.1055/s-0041-1739169

Seminars in Reproductive Medicine, Table of Contents

Semin Reprod Med 2021; 39(05/06): e19-e21
DOI: 10.1055/s-0041-1739169

Epilogue

Navigating Innovation, Evidence-based Practice and Patient Choice in ART: Concluding Comments on Adjuvant Therapies

Thomas Tang

¹Regional Fertility Centre, Royal Jubilee Maternity Service, Belfast HSC Trust, Belfast, United Kingdom

,

Nikoletta Panagiotopoulou

²Department of Gynaecology, Salford Royal NHS Foundation Trust, Salford, United Kingdom

³Manchester Fertility, Cheadle, United Kingdom

,

Ephia Yasmin

⁴Reproductive Medicine Unit, University College London Hospital, London, United Kingdom

› Author Affiliations

Abstract

Full Text

References

References
1 Human Fertilisation and Embryology Authority. Fertility treatment 2018: trends and figures. Accessed September 2020 at: https://www.hfea.gov.uk/about-us/publications/research-and-data/fertility-treatment-2018-trends-and-figures/
2 Centers for Disease Control and Prevention. Assisted reproductive technology (ART) data. Accessed September 2020 at: https://nccd.cdc.gov/drh_art/rdPage.aspx?rdReport=DRH_ART.ClinicInfo&rdRequestForwarr=True&ClinicId=9999&ShowNational=1
3 National Perinatal Epidemiology and Statistics Unit. Assisted reproductive technology in Australia and New Zealand 2017. Accessed September 2020 at: https://npesu.unsw.edu.au/sites/default/files/npesu/surveillances/Assisted%20Reproductive%20Technology%20in%20Australia%20and%20New%20Zealand%202017%20Summary.ppd
4 Human Fertilisation and Embryology Authority. Pilot national fertility patient survey. 2018. Accessed September 2020 at: https://www.hfea.gov.uk/media/2702/pilot-national-fertility-patient-survey-2018.pdf
5 Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 1992; 340 (8810): 17-18
6 Duffy JM. Priorities for future infertility research. Hum Reprod Abstract Book. 2019; Suppl. 1; O156:i69. https://cm.eshre.eu/presentations/ESHRE2019/O-156/default.aspx
7 Harper J, Magli MC, Lundin K, Barratt CLR, Brison D. When and how should new technology be introduced into the IVF laboratory?. Hum Reprod 2012; 27 (02) 303-313
8 Braakhekke M, Mol F, Mastenbroek S, Mol BW, van der Veen F. Equipoise and the RCT. Hum Reprod 2017; 32 (02) 257-260
9 Human Fertilisation and Embryology Authority. The responsible use of treatment add-ons in fertility services: a consensus statement. 2019 . Accessed September 2020 at: https://www.hfea.gov.uk/media/2792/treatment-add-ons-consensus-statement-final.pdf
10 Lensen S, Hammarberg K, Polyakov A. et al. How common is add-on use and how do patients decide whether to use them? A national survey of IVF patients. Hum Reprod 2021; 36 (07) 1854-1861
11 Schopen F. How IVF became a licence to print money [Internet]. The Guardian; 2018 [cited 11 June 2021]. Available from: https://www.theguardian.com/lifeandstyle/2018/jun/18/how-ivf-became-a-licence-to-print-money